EyePoint Pharmaceuticals Inc. buy Cantor Fitzgerald
Start price
08.07.26
/
50%
€12.20
Target price
08.07.27
€41.17
Performance (%)
-1.64%
Price
06.08.26
€10.10
Summary
This prediction is currently active. With a performance of -1.64%, the BUY prediction by Cantor_Fitzgerald is trending in the wrong direction. This prediction currently runs until 08.07.27. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| EyePoint Pharmaceuticals Inc. | 2.020% |
| iShares Core DAX® | 2.573% |
| iShares Nasdaq 100 | 4.858% |
| iShares Nikkei 225® | 5.590% |
| iShares S&P 500 | 3.250% |
Comments by Cantor_Fitzgerald for this prediction
In the thread EyePoint Pharmaceuticals Inc. diskutieren
Eyepoint Pharmaceuticals (EYPT) had its "overweight" rating reaffirmed by Cantor Fitzgerald. They now have a $47.00 price target on the stock.
Ratings data for EYPT provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€11.30
06.08.26
06.08.26
€47.61
06.08.27
06.08.27
6.19%
06.08.26
06.08.26
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€7.48
20.06.24
20.06.24
-
20.06.25
20.06.25
-6.79%
21.06.25
21.06.25
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€10.20
14.09.23
14.09.23
€29.02
14.09.24
14.09.24
-18.55%
15.09.24
15.09.24
EyePoint Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€9.00
31.08.23
31.08.23
€28.59
31.08.24
31.08.24
-13.24%
01.09.24
01.09.24